Last reviewed · How we verify
Amoxicillin active phase
At a glance
| Generic name | Amoxicillin active phase |
|---|---|
| Also known as | AMX 1 |
| Sponsor | Belén Retamal-Valdes |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori (PHASE3)
- Combination Study of Antibiotics With Enzalutamide (PROMIZE) (PHASE1, PHASE2)
- A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis (PHASE3)
- Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis (NA)
- Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis (NA)
- Prophylactic Antibiotic Treatment in Hemodialysis (NA)
- Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB (PHASE2)
- Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amoxicillin active phase CI brief — competitive landscape report
- Amoxicillin active phase updates RSS · CI watch RSS
- Belén Retamal-Valdes portfolio CI